- Home
- GHRS vs HAFC Comparison
GHRS vs HAFC Comparison
Compare GHRS & HAFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GHRS | HAFC |
|---|---|---|
| Founded | 2018 | 1982 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 947.2M | 821.2M |
| IPO Year | 2021 | 2000 |
Fundamental Metrics
Financial Performance| Metric | GHRS | HAFC |
|---|---|---|
| Price | $21.47 | $29.40 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 8 | 3 |
| Target Price | ★ $41.38 | $32.17 |
| AVG Volume (30 Days) | ★ 255.6K | 230.4K |
| Earning Date | 05-01-2026 | 04-21-2026 |
| Dividend Yield | N/A | ★ 3.75% |
| EPS Growth | N/A | ★ 22.44 |
| EPS | N/A | ★ 0.75 |
| Revenue | N/A | ★ $270,165,000.00 |
| Revenue This Year | N/A | $18.65 |
| Revenue Next Year | N/A | $7.28 |
| P/E Ratio | ★ N/A | $39.45 |
| Revenue Growth | N/A | ★ 15.28 |
| 52 Week Low | $9.52 | $21.84 |
| 52 Week High | $24.66 | $31.33 |
Technical Indicators
Market Signals| Indicator | GHRS | HAFC |
|---|---|---|
| Relative Strength Index (RSI) | 61.88 | 53.38 |
| Support Level | $12.29 | $29.20 |
| Resistance Level | $24.66 | $29.83 |
| Average True Range (ATR) | 1.26 | 0.70 |
| MACD | -0.02 | -0.13 |
| Stochastic Oscillator | 67.11 | 21.49 |
Price Performance
Historical ComparisonAbout GHRS GH Research PLC
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.
About HAFC Hanmi Financial Corporation
Hanmi Financial Corp is a Los Angeles-based bank that caters to Korean-Americans and other multi-ethnic communities across California, Colorado, Georgia, Illinois, New Jersey, New York, Texas, Virginia, and Washington. The bank mainly focuses on small businesses and commercial and real estate loans. It also offers a variety of international finance and trade services and products, including letters of credit, import financing, and export financing. The Bank's revenues are derived from interest and fees on loans, interest, and dividends on the securities portfolio, service charges on deposit accounts, and sales of SBA loans.